Published in Eur J Pediatr on November 01, 1997
Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol (2003) 1.19
Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis (1998) 1.15
Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 1.14
Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis (1999) 1.08
Recurrent rhabdomyolysis in a child with glutaric aciduria type I. J Inherit Metab Dis (1999) 0.96
Maintenance treatment of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.93
Cognitive, behavioural and adaptive profiles of children with glutaric aciduria type I detected through newborn screening. J Inherit Metab Dis (2009) 0.86
Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options. J Inherit Metab Dis (2004) 0.77
Glutaric aciduria type 1 and neonatal screening: time to proceed--with caution. Eur J Pediatr (2003) 0.76
An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist. Ann Indian Acad Neurol (2008) 0.75
Leukotrienes in the pathophysiology of kwashiorkor. Lancet (1993) 3.14
White matter disease in cerebral organic acid disorders: clinical implications and suggested pathomechanisms. Neuropediatrics (2002) 2.10
Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet (1999) 2.07
Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology (2010) 1.88
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet (1998) 1.78
Screening for defects of branched-chain amino acid metabolism. Eur J Pediatr (1994) 1.67
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis (2008) 1.56
Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr (2000) 1.45
Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics (2000) 1.44
Abuse or metabolic disorder? Arch Dis Child (1998) 1.42
D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity? Ann Neurol (1999) 1.41
Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 1.41
4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics (1998) 1.37
Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis (2007) 1.31
Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology (2005) 1.26
Mutation analysis in glutaric aciduria type I. J Med Genet (2000) 1.23
Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach. J Inherit Metab Dis (2007) 1.22
Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS). J Inherit Metab Dis (2007) 1.20
High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr (2009) 1.19
L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol (1992) 1.16
Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis (1998) 1.15
Acrodermatitis acidemica secondary to malnutrition in glutaric aciduria type I. Eur J Dermatol (2001) 1.14
Pyridoxal phosphate-dependent neonatal epileptic encephalopathy. Arch Dis Child Fetal Neonatal Ed (2008) 1.12
Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatr Res (2000) 1.10
Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. Eur J Hum Genet (2001) 1.09
Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem (1998) 1.09
Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice). Neurochem Int (2007) 1.08
Leukotrienes: biosynthesis, metabolism, and pathophysiologic significance. Pediatr Res (1995) 1.08
Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis (1999) 1.08
Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up. J Inherit Metab Dis (2009) 1.08
Implementation of extended neonatal screening and a metabolic unit in the State of Qatar: developing and optimizing strategies in cooperation with the Neonatal Screening Center in Heidelberg. J Inherit Metab Dis (2007) 1.03
Phenylketonuria mutations in Germany. Hum Genet (1999) 1.01
Erythropoietic and hepatic porphyrias. J Inherit Metab Dis (2000) 1.00
Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins. J Inherit Metab Dis (1997) 0.99
Molecular and functional characterisation of mild MCAD deficiency. Hum Genet (2001) 0.99
Stable-isotope dilution analysis of D- and L-2-hydroxyglutaric acid: application to the detection and prenatal diagnosis of D- and L-2-hydroxyglutaric acidemias. Pediatr Res (1993) 0.99
Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome. J Inherit Metab Dis (2007) 0.98
Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence. J Biol Chem (1996) 0.98
Neonatal screening for glutaric aciduria type I: strategies to proceed. J Inherit Metab Dis (2006) 0.97
A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet (2000) 0.97
Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. Am J Hum Genet (1999) 0.96
A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. J Inherit Metab Dis (2002) 0.96
Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry. J Inherit Metab Dis (2005) 0.96
Large heterozygous deletion masquerading as homozygous missense mutation: a pitfall in diagnostic mutation analysis. J Inherit Metab Dis (1999) 0.95
Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I. Clin Chem (2001) 0.95
Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies. Neuropediatrics (2002) 0.95
Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome. J Neurol Sci (2001) 0.95
Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF. Neurology (2004) 0.94
Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis (2009) 0.94
Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome. J Inherit Metab Dis (2008) 0.94
Maintenance treatment of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.93
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism. J Inherit Metab Dis (2008) 0.92
Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.92
A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations. Neuropediatrics (2001) 0.92
Expanded newborn screening in Europe 2007. J Inherit Metab Dis (2007) 0.92
Newborn screening for methylmalonic acidurias--optimization by statistical parameter combination. J Inherit Metab Dis (2008) 0.92
L-2-hydroxyglutaric acidaemia: clinical and biochemical findings in 12 patients and preliminary report on L-2-hydroxyacid dehydrogenase. J Inherit Metab Dis (1993) 0.91
Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation? J Inherit Metab Dis (1997) 0.91
Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency. Neuropediatrics (2006) 0.91
Glutaric aciduria and suspected child abuse. Arch Dis Child (1999) 0.91
Qualitative urinary organic acid analysis: methodological approaches and performance. J Inherit Metab Dis (2008) 0.90
Abnormal sterol metabolism in holoprosencephaly: studies in cultured lymphoblasts. J Med Genet (2007) 0.90
Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency. Am J Med Genet (1998) 0.90
Inherited disorders of cholesterol biosynthesis. Neuropediatrics (2001) 0.90
Congenital disorder of glycosylation IId (CDG-IId) -- a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics (2002) 0.90
Emergency treatment in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.90
Identification of an active site alanine in mevalonate kinase through characterization of a novel mutation in mevalonate kinase deficiency. J Biol Chem (1997) 0.90
Emergency management of inherited metabolic diseases. J Inherit Metab Dis (2002) 0.89
Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglutaric aciduria? Neuropediatrics (2000) 0.89
Early onset epilepsy and inherited metabolic disorders: diagnosis and management. Can J Neurol Sci (2010) 0.89
Atypical (mild) forms of dihydropteridine reductase deficiency: neurochemical evaluation and mutation detection. Pediatr Res (1992) 0.89
Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology (2006) 0.87
Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency. J Pediatr (1993) 0.87
Mental retardation and inborn errors of metabolism. J Inherit Metab Dis (2009) 0.87
3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. J Neurosci Res (2001) 0.86
A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). J Inherit Metab Dis (1999) 0.86
Neurotransmitter metabolites in CSF: an external quality control scheme. J Inherit Metab Dis (2002) 0.86
Biochemistry of glutaric aciduria type I: activities of in vitro expressed wild-type and mutant cDNA encoding human glutaryl-CoA dehydrogenase. J Inherit Metab Dis (1999) 0.86
Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics (2003) 0.85
Glutaric aciduria type III: a distinctive non-disease? J Inherit Metab Dis (2002) 0.85
Increased urinary excretion of dicarboxylic acids and 4-hydroxyphenyllactic acid in patients with Zellweger syndrome. Eur J Pediatr (1995) 0.85
Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading. J Inherit Metab Dis (1999) 0.85
beta-Ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn Reson Med (2001) 0.85
Impaired synthesis of lipoxygenase products in glutathione synthetase deficiency. Pediatr Res (1994) 0.85
Glutaric aciduria type I: ultrasonographic demonstration of early signs. Pediatr Radiol (1999) 0.85
5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic anaemia. J Inherit Metab Dis (1995) 0.84
Sedation with 4-hydroxybutyric acid: a potential pitfall in the diagnosis of SSADH deficiency. J Inherit Metab Dis (2004) 0.84
Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Clin Chem (1999) 0.84
Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis (2009) 0.84
Does prolonged breastfeeding reduce the risk for childhood leukemia and lymphomas? Minerva Pediatr (2008) 0.84
Confirmation of the enzyme defect in the first case of beta-ureidopropionase deficiency. Beta-alanine deficiency. Adv Exp Med Biol (2000) 0.84
Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology (2005) 0.84
Inborn errors of metabolism at the turn of the millennium. Croat Med J (2001) 0.84
Methylmalonic acid induces excitotoxic neuronal damage in vitro. J Inherit Metab Dis (2000) 0.83
D-2-hydroxyglutaric aciduria: further clinical delineation. J Inherit Metab Dis (1999) 0.83
Use of the middle colic vein for liver cell transplantation in infants and small children. Transplant Proc (2008) 0.83
[Kawasaki syndrome. Association with exposure to carpet shampoo and successful therapy with immunoglobulins in the second week of the illness]. Monatsschr Kinderheilkd (1992) 0.83
Mutation analysis in glycogen storage disease type 1 non-a. Hum Genet (2000) 0.83
A severely affected infant with absence of cysteinyl leukotrienes in cerebrospinal fluid: further evidence that leukotriene C4-synthesis deficiency is a new neurometabolic disorder. Neuropediatrics (1999) 0.82